We came across a bullish thesis on Amprius Technologies, Inc. on Danny’s Substack by Danny Green. In this article, we will summarize the bulls’ thesis on AMPX. Amprius Technologies, Inc.’s share was trading at $10.73 as of February 27th.

Photo by Kumpan Electric on Unsplash
Amprius Technologies, Inc. develops, manufactures, and markets lithium-ion batteries for mobility applications. AMPX represents a high-risk, high-reward growth story positioned at the intersection of electrification, aviation, drones, and defense. The company benefits from strong structural tailwinds as demand for high-performance batteries accelerates across advanced mobility applications.
Its proprietary silicon anode technology directly addresses key lithium-ion limitations by significantly improving energy density and power output, with commercially available cells reaching roughly 450–500 Wh/kg—well above conventional EV batteries. Product differentiation, including ultra-fast charging and wide temperature performance, strengthens its positioning in specialized markets where performance outweighs cost sensitivity.
Operational momentum has been notable. Q2 2025 revenue surged 350% year-over-year to $15.1 million, marking the first positive gross margin (9%), while Q3 sustained strong growth (~173% YoY) with margins expanding to approximately 15%. First-half 2025 revenue of $26.4 million already surpassed full-year 2024 results, signaling accelerating commercialization. Customer expansion to 93 accounts, alongside growing defense engagement and manufacturing partnerships in South Korea providing over 500 MWh of capacity, supports near-term scaling.
However, profitability remains fragile. Net operating losses persist, cash burn is elevated, and capital requirements for large-scale facilities—such as planned GWh production in Colorado—introduce execution and funding risk. The battery industry remains intensely competitive, with solid-state and alternative chemistries advancing rapidly. Heavy reliance on contract manufacturers and global supply chains adds geopolitical and cost volatility exposure.
The investment case is asymmetrical. If production scales successfully and margins continue expanding, the company’s differentiated technology could justify a meaningful valuation rerating. Conversely, delays, dilution, or operational setbacks could pressure the stock significantly. As such, AMPX fits best as a small, tactical allocation within a diversified portfolio, suited for investors seeking aggressive early-stage growth exposure.
Previously, we covered a bullish thesis on Enovix Corporation (ENVX) by jamesfreakinbond84 in February 2025, which highlighted the company’s disruptive 3D battery architecture, strong intellectual property portfolio, strategic partnerships, and commercialization roadmap. ENVX’s stock price has depreciated by approximately 54.09% since our coverage due to lower analyst expectations, and the inherent volatility of a growth-oriented, pre-profit tech manufacturer. Danny Green shares a similar view but emphasizes on Amprius Technologies’ rapid revenue growth, silicon anode differentiation, and manufacturing scale-up risks.
Amprius Technologies, Inc. is not on our list of the 40 Most Popular Stocks Among Hedge Funds. As per our database, 27 hedge fund portfolios held AMPX at the end of the fourth quarter which was 30 in the previous quarter. While we acknowledge the risk and potential of AMPX as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than AMPX and that has 10,000% upside potential, check out our report about this cheapest AI stock.
Update: This article is a summary of a write-up that was published a month ago. We received the following comment from a reader regarding this summary:
Your report erroneously claims that Amprius is facing execution risks regarding a “planned GWh production in Colorado.” This information is over a month out of date. As disclosed in the SEC Form 8-K filed on February 3, 2026, Amprius officially terminated the Colorado lease and paid a termination fee to pivot to a “capital-light” manufacturing model.
Furthermore, the article fails to account for the $125 million revenue guidance and projected positive Adjusted EBITDA released in today’s earnings report (March 5, 2026). By focusing on “challenges in profitability” and a non-existent factory, the article provides a demonstrably false narrative to your readers and investors.
Disclosure: None.

